Can Dance Therapy Improve Motor Learning in Parkinson's Disease (PD)?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-01

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In order to find the most effective rehabilitative therapies for Parkinsonian patients, the present study is aimed to evaluate whether, in a multidisciplinary intensive rehabilitation treatment, the dance therapy, applied to the motor learning, promote additional benefits.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cognitive, Affective, and Motor Effects of Tangotherapy in Parkinson's Disease

NCT05904171

Parkinson Disease

COMPLETED NA

Effectiveness of Intensive Rehabilitation in Advanced Stages of Parkinson's Disease.

NCT02731170

Parkinson Disease

UNKNOWN NA

Effects of a Dance and Walking Program for People With Parkinson's Disease

NCT03370315

Parkinson Disease

COMPLETED NA

Telerehabilitation Using a Dance Intervention in People With Parkinson's Disease

NCT04580849

Parkinson Disease

COMPLETED NA

Dance Well Therapy: a Study for Evaluating Efficacy, Safety, and Feasibility

NCT06896123

Parkinson Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants are randomly assigned to experimental group or control group. Both of the groups undergo a rehabilitation treatment. The experimental group undergoes 4-week MIRT (Multidisciplinary Intensive Rehabilitation Treatment) + dance therapy. The control group undergoes 4-week MIRT (Multidisciplinary Intensive Rehabilitation Treatment) + exercises

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

The investigator are neurologists, blinded to the treatment received by the patient

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

dance thrapy

4-week Multidisciplinary Rehabilitation Treatment + Dance Therapy Treatment (2 hours par week)

Group Type EXPERIMENTAL

Dance Therapy

Intervention Type BEHAVIORAL

the intervention is aimed to ameliorate, through dancing, crucial motor symptoms in PD patients, as walking, balance, postural changes and arm swing

exercises without dance

4-week Multidisciplinary Rehabilitation Treatment + Exercises without music (2 hours par week)

Group Type ACTIVE_COMPARATOR

exercises without dance

Intervention Type BEHAVIORAL

the intervention consists of exercises aimed at training the walking, the balance, the postural changes and the arm swing

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dance Therapy

the intervention is aimed to ameliorate, through dancing, crucial motor symptoms in PD patients, as walking, balance, postural changes and arm swing

Intervention Type BEHAVIORAL

exercises without dance

the intervention consists of exercises aimed at training the walking, the balance, the postural changes and the arm swing

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Stage 2.5-3 according to the Hoehn and Yahr scale (H\&Y);
* Stable pharmacological treatment for the last 6 weeks before the enrolment and during the hospitalization;

Exclusion Criteria

* Any focal brain lesion detected in brain imaging studies (CT or MRI) performed in the previous 12 months;
* Drug-induced dyskinesias;
* Disturbing resting and/or action tremor, corresponding to scores 2-4 in the specific items of UPDRS III;
* Behavioral disturbances (evaluated with Neuropsychiatric Inventory);
* Visual and auditory dysfunctions according to the general clinical evaluation and medical history;
* cognitive decline (MMSE correct score \< 24)

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Giuseppe Frazzitta, MD

Role: PRINCIPAL_INVESTIGATOR

Department of Parkinson's disease, Movement Disorders and Brain Injury Rehabilitation, "Moriggia-Pelascini" Hospital - Via Pelascini, 3, 22015, Gravedona ed Uniti, Como, Italy